Immunoreactivity for interleukin 3 and 5 and granulocyte/macrophage colony-stimulating factor of intestinal mucosa in bronchial asthma.

PubWeight™: 1.22‹?› | Rank: Top 10%

🔗 View Article (PMC 2192256)

Published in J Exp Med on December 01, 1995

Authors

B Wallaert1, P Desreumaux, M C Copin, I Tillie, A Benard, J F Colombel, B Gosselin, A B Tonnel, A Janin

Author Affiliations

1: Service de Pneumologie et Immuno-allergologie, Hôpital A. Calmette, Lille, France.

Articles citing this

Requirements for allergen-induced airway hyperreactivity in T and B cell-deficient mice. Mol Med (1998) 2.59

Gastrointestinal symptoms in patients with asthma. Arch Dis Child (2000) 1.82

Mouse mast cell tryptase mMCP-6 is a critical link between adaptive and innate immunity in the chronic phase of Trichinella spiralis infection. J Immunol (2008) 1.53

Two highly homologous ribonuclease genes expressed in mouse eosinophils identify a larger subgroup of the mammalian ribonuclease superfamily. Proc Natl Acad Sci U S A (1996) 1.19

Gastrointestinal eosinophils in health, disease and functional disorders. Nat Rev Gastroenterol Hepatol (2010) 1.06

Increased prevalence of gastrointestinal symptoms in patients with allergic disease. Postgrad Med J (2007) 1.04

Role of the high affinity immunoglobulin E receptor in bacterial translocation and intestinal inflammation. J Exp Med (2001) 0.91

Analysis of Gastric and Duodenal Eosinophils in Children with Abdominal Pain Related Functional Gastrointestinal Disorders According to Rome III Criteria. J Neurogastroenterol Motil (2016) 0.89

Intestinal permeability is increased in bronchial asthma. Arch Dis Child (2004) 0.86

The role of eosinophils in inflammatory bowel disease. Gut (2005) 0.85

Clinical Characteristics, Comorbidities and Hospital Outcomes in Hospitalizations with Cyclic Vomiting Syndrome: A Nationwide Analysis. Dig Dis Sci (2017) 0.84

The impact of asthma on the gastrointestinal tract (GIT). J Asthma Allergy (2010) 0.79

Intestinal allergic inflammation in birch pollen allergic patients in relation to pollen season, IgE sensitization profile and gastrointestinal symptoms. Clin Transl Allergy (2014) 0.78

Self-reported adverse reactions and IgE sensitization to common foods in adults with asthma. Clin Transl Allergy (2015) 0.75

A digestive allergic reaction with hypereosinophilia imputable to docetaxel in a breast cancer patient: a case report. BMC Cancer (2015) 0.75

Interleukin-3 production by mast cells from human lung. Inflammation (1999) 0.75

Articles cited by this

Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology (1992) 10.44

Eosinophilic inflammation in asthma. N Engl J Med (1990) 8.05

Mucosal inflammation in asthma. Am Rev Respir Dis (1990) 4.11

Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest (1991) 3.88

Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis (1989) 3.86

Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am Rev Respir Dis (1990) 3.70

Production of the haemopoietic growth factors GM-CSF and interleukin-3 by mast cells in response to IgE receptor-mediated activation. Nature (1989) 3.15

Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol (1994) 2.73

Repopulation with IgA-containing cells of bronchial and intestinal lamina propria after transfer of homologous Peyer's patch and bronchial lymphocytes. J Immunol (1975) 2.57

The relationship between infiltrating CD4+ lymphocytes, activated eosinophils, and the magnitude of the allergen-induced late phase cutaneous reaction in man. J Immunol (1988) 2.00

Immunohistochemical studies of the formation and epithelial transport of immunoglobulins in normal and diseased human intestinal mucosa. Scand J Gastroenterol Suppl (1976) 1.92

Interleukin 5 messenger RNA expression by eosinophils in the intestinal mucosa of patients with coeliac disease. J Exp Med (1992) 1.88

Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics. J Clin Invest (1992) 1.81

Granulocyte/macrophage colony-stimulating factor and interleukin 3 release from human peripheral blood eosinophils and neutrophils. J Exp Med (1991) 1.77

Induction of IgE-secreting cells and IgE isotype-specific suppressor T cells in the respiratory lymph nodes of rats in response to antigen inhalation. Cell Immunol (1985) 1.73

Expression of mRNA and immunoreactivity for the granulocyte/macrophage colony-stimulating factor in activated human eosinophils. J Exp Med (1991) 1.64

Concept of the local and common mucosal immune response. Adv Exp Med Biol (1978) 1.46

A mouse T cell product that preferentially enhances IgA production. I. Biologic characterization. J Immunol (1987) 1.44

Glucocorticoids inhibit cytokine-mediated eosinophil survival. J Immunol (1991) 1.29

Induction of IgE-isotype specific tolerance by passive antigenic stimulation of the respiratory mucosa. Immunology (1983) 1.24

Endoscopic biopsies of normal duodenal mucosa. Gastrointest Endosc (1974) 1.10

Regulation of lymphoblast traffic and localization in mucosal tissues, with emphasis on IgA. Fed Proc (1983) 1.01

Activated eosinophils in adult coeliac disease: evidence for a local release of major basic protein. Gut (1992) 0.91

Airway-like inflammation of minor salivary gland in bronchial asthma. Am J Respir Crit Care Med (1994) 0.86

Lymphocytes in the lung: should we continue to exalt only BALT? Am J Respir Cell Mol Biol (1990) 0.79

Articles by these authors

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature (2001) 33.12

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management. J Crohns Colitis (2010) 6.75

Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature (1996) 5.44

Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology (1998) 5.02

Dysbiosis in inflammatory bowel disease. Gut (2004) 5.01

Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut (1998) 3.45

European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis (2009) 3.22

Activation of the peroxisome proliferator-activated receptor gamma promotes the development of colon tumors in C57BL/6J-APCMin/+ mice. Nat Med (1998) 3.13

Preoperative imaging of parathyroid glands with technetium-99m-labelled sestamibi and iodine-123 subtraction scanning in secondary hyperparathyroidism. Lancet (1999) 2.79

Immunocytochemical evidence of Listeria, Escherichia coli, and Streptococcus antigens in Crohn's disease. Gastroenterology (1995) 2.47

Expression of human mucin genes in respiratory, digestive, and reproductive tracts ascertained by in situ hybridization. J Histochem Cytochem (1993) 2.46

Bronchogenic cysts of the mediastinum. J Thorac Cardiovasc Surg (1995) 2.39

Genetic analyses of chromosome 12 loci in Crohn's disease. Gut (2000) 2.30

Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death. Infect Immun (2001) 2.28

Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies. J Exp Med (2001) 2.21

Heterogeneity of human peripheral blood eosinophils: variability in cell density and cytotoxic ability in relation to the level and the origin of hypereosinophilia. Int Arch Allergy Appl Immunol (1983) 2.17

An in-depth study of Crohn's disease in two French families. Gastroenterology (1993) 2.15

European evidence-based Consensus on the management of ulcerative colitis: Current management. J Crohns Colitis (2008) 2.14

Release of prostaglandin D2 into human airways during acute antigen challenge. N Engl J Med (1986) 2.03

Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohn's disease. Am J Gastroenterol (1998) 2.03

A unique PPARgamma ligand with potent insulin-sensitizing yet weak adipogenic activity. Mol Cell (2001) 2.02

Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion. J Exp Med (1994) 2.01

Does one size fit all? Drug resistance and standard treatments: results of six tuberculosis programmes in former Soviet countries. Int J Tuberc Lung Dis (2005) 2.01

PPARgamma as a new therapeutic target in inflammatory bowel diseases. Gut (2006) 1.99

Diagnostic efficiency of endotracheal aspirates with quantitative bacterial cultures in intubated patients with suspected pneumonia. Comparison with the protected specimen brush. Am Rev Respir Dis (1993) 1.94

Dysbiosis as a prerequisite for IBD. Gut (2004) 1.93

Retinoic acid and arsenic synergize to eradicate leukemic cells in a mouse model of acute promyelocytic leukemia. J Exp Med (1999) 1.91

Specific antibody response to oligomannosidic epitopes in Crohn's disease. Clin Diagn Lab Immunol (1996) 1.89

Interleukin 5 messenger RNA expression by eosinophils in the intestinal mucosa of patients with coeliac disease. J Exp Med (1992) 1.88

Incidence of inflammatory bowel disease in northern France (1988-1990). Gut (1994) 1.81

Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus. Am J Respir Crit Care Med (1999) 1.77

Adverse events in phase-I studies: a report in 1015 healthy volunteers. Eur J Clin Pharmacol (1998) 1.73

Interleukin 3, granulocyte-macrophage colony-stimulating factor, and interleukin 5 in eosinophilic gastroenteritis. Gastroenterology (1996) 1.73

Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: a multicenter placebo-controlled study. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID) Gastroenterology (1993) 1.71

Methotrexate in Crohn's disease: long-term efficacy and toxicity. Am J Gastroenterol (2000) 1.69

Distinct cytokine patterns in early and chronic ileal lesions of Crohn's disease. Gastroenterology (1997) 1.69

Inflammatory alterations in mesenteric adipose tissue in Crohn's disease. Gastroenterology (1999) 1.68

Treatment of diversion colitis by short-chain fatty acids. Prospective and double-blind study. Dis Colon Rectum (1991) 1.65

Enterocolitis induced by autoimmune targeting of enteric glial cells: a possible mechanism in Crohn's disease? Proc Natl Acad Sci U S A (2001) 1.63

ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines. J Biol Chem (1996) 1.63

Latent pulmonary involvement in Crohn's disease: biological, functional, bronchoalveolar lavage and scintigraphic studies. Gut (1986) 1.63

Long-term prognosis of near-fatal asthma. A 6-year follow-up study of 145 asthmatic patients who underwent mechanical ventilation for a near-fatal attack of asthma. Am Rev Respir Dis (1992) 1.63

Genetically related Escherichia coli strains associated with Crohn's disease. Gut (2001) 1.61

Lymphocyte subpopulations in bronchoalveolar lavage in Sjögren's syndrome. Evidence for an expansion of cytotoxic/suppressor subset in patients with alveolar neutrophilia. Chest (1987) 1.60

Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial. Gut (2005) 1.58

Inflammatory bowel disease in married couples: 10 cases in Nord Pas de Calais region of France and Liège county of Belgium. Gut (1994) 1.57

Early development of stricturing or penetrating pattern in Crohn's disease is influenced by disease location, number of flares, and smoking but not by NOD2/CARD15 genotype. Gut (2003) 1.55

Perioperative endoscopy of the whole small bowel in Crohn's disease. Gut (1993) 1.54

Renal insufficiency in infant: side-effect of prenatal exposure to mesalazine? Lancet (1994) 1.53

Association between myelodysplastic syndromes and inflammatory bowel diseases. Report of seven new cases and review of the literature. Leukemia (1997) 1.50

Specific mucosal erosions in hypereosinophilic syndrome. Evidence for eosinophil protein deposition. Arch Dermatol (1996) 1.48

High-dose and low-dose systemic corticosteroids are equally efficient in acute severe asthma. Eur Respir J (1995) 1.48

[Treatment of pulmonary lymphangioleiomyomatosis using a GnRH agonist]. Rev Mal Respir (1996) 1.48

Increased secretion of tumor necrosis factor alpha and interleukin-6 by alveolar macrophages consecutive to the development of the late asthmatic reaction. J Allergy Clin Immunol (1991) 1.46

Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's disease. Inflamm Bowel Dis (2001) 1.44

Brachmann-de Lange syndrome: pre- and postnatal findings. Am J Med Genet (1996) 1.44

Involvement of immunoglobulin E in the secretory processes of alveolar macrophages from asthmatic patients. J Clin Invest (1983) 1.44

[Cytokeratins 7 and 20: aid in tumor typing]. Ann Pathol (1998) 1.43

Diagnostic tests for pneumonia in ventilated patients: prospective evaluation of diagnostic accuracy using histology as a diagnostic gold standard. Am J Respir Crit Care Med (1995) 1.42

Enzyme release and superoxide anion production by human alveolar macrophages stimulated with immunoglobulin E. Clin Exp Immunol (1980) 1.42

Bilateral renal oncocytosis with renal failure. Arch Pathol Lab Med (2001) 1.41

[Infliximab therapy for Crohn's disease anoperineal lesions]. Gastroenterol Clin Biol (2001) 1.40

Deep venous thrombosis and antibodies to cyproterone acetate. Lancet (1990) 1.40

[Eosinophils and pathology of the digestive tract]. Gastroenterol Clin Biol (1990) 1.38

Card15 gene overexpression in mononuclear and epithelial cells of the inflamed Crohn's disease colon. Gut (2003) 1.38

[Epstein-Barr virus: pathologic implications]. Ann Pathol (1998) 1.38

[Treatment, by embolization, of severe or repeated hemoptysis associated with systemic hypervascularization]. Nouv Presse Med (1973) 1.37

[Auricular chondritis, malignant glomerulonephritis and pulmonary hemorrhage]. Nephrologie (1991) 1.37

Peroxisome proliferator-activated receptor gamma activators affect the maturation of human monocyte-derived dendritic cells. Eur J Immunol (2001) 1.36

Peroxisome proliferator-activated receptor gamma is induced during differentiation of colon epithelium cells. J Endocrinol (1999) 1.35

Fire-eater's lung: seventeen cases and a review of the literature. Medicine (Baltimore) (2001) 1.34

Multilocus sequence typing reveals intrafamilial transmission and microevolutions of Candida albicans isolates from the human digestive tract. J Clin Microbiol (2006) 1.34

Bronchial neutrophilia in patients with noninfectious status asthmaticus. Am J Respir Crit Care Med (1998) 1.34

Fecal beta-D-galactosidase production and Bifidobacteria are decreased in Crohn's disease. Dig Dis Sci (1997) 1.33

Selective expansion of intraepithelial lymphocytes expressing the HLA-E-specific natural killer receptor CD94 in celiac disease. Gastroenterology (2000) 1.33

c-ets1 proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans. Am J Pathol (1992) 1.33

Neutrophil and eosinophil involvement of the small bowel in patients with celiac disease and Crohn's disease: studies on the secretion rate and immunohistochemical localization of granulocyte granule constituents. Am J Med (1989) 1.33

Developmental mucin gene expression in the human respiratory tract. Am J Respir Cell Mol Biol (1999) 1.32

Importance of ground-glass attenuation in chronic diffuse infiltrative lung disease: pathologic-CT correlation. Radiology (1993) 1.31